Development of Parkinson's disease in patients with blepharospasm.
Identifieur interne : 000F35 ( Ncbi/Curation ); précédent : 000F34; suivant : 000F36Development of Parkinson's disease in patients with blepharospasm.
Auteurs : Federico Micheli [Argentine] ; María Clara Scorticati ; Silvia Folgar ; Emilia GattoSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Botulinum Toxins, Type A (therapeutic use), Brain (pathology), Brain (physiopathology), Brain (radiography), Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Meige Syndrome (diagnosis), Meige Syndrome (drug therapy), Meige Syndrome (epidemiology), Neuromuscular Agents (therapeutic use), Parkinson Disease (diagnosis), Parkinson Disease (epidemiology), Parkinson Disease (physiopathology), Severity of Illness Index, Tomography, X-Ray Computed.
- MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A, Neuromuscular Agents.
- diagnosis : Meige Syndrome, Parkinson Disease.
- drug therapy : Meige Syndrome.
- epidemiology : Meige Syndrome, Parkinson Disease.
- pathology : Brain.
- physiopathology : Brain, Parkinson Disease.
- radiography : Brain.
- Aged, Aged, 80 and over, Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Severity of Illness Index, Tomography, X-Ray Computed.
Abstract
The liability to develop parkinsonian symptoms was evaluated in 105 outpatients with idiopathic blepharospasm (IBS; 54 cases) or IBS associated to oromandibular dystonia (Meige's syndrome; 51 cases) mean age 70.3 +/- 9.6 years, and compared with an age- and sex-matched population. Eleven patients developed Parkinson's disease in the blepharospasm group, whereas only 2 of 105 patients were affected in the control group. Our results suggest that patients with IBS either isolated or associated with oromandibular dystonia are more prone to develop parkinsonian symptoms.
DOI: 10.1002/mds.20084
PubMed: 15372598
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003353
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003353
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003496
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000F35
Links to Exploration step
pubmed:15372598Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of Parkinson's disease in patients with blepharospasm.</title><author><name sortKey="Micheli, Federico" sort="Micheli, Federico" uniqKey="Micheli F" first="Federico" last="Micheli">Federico Micheli</name><affiliation wicri:level="1"><nlm:affiliation>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina. fmicheli@fibertel.com.ar</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Scorticati, Maria Clara" sort="Scorticati, Maria Clara" uniqKey="Scorticati M" first="María Clara" last="Scorticati">María Clara Scorticati</name></author><author><name sortKey="Folgar, Silvia" sort="Folgar, Silvia" uniqKey="Folgar S" first="Silvia" last="Folgar">Silvia Folgar</name></author><author><name sortKey="Gatto, Emilia" sort="Gatto, Emilia" uniqKey="Gatto E" first="Emilia" last="Gatto">Emilia Gatto</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15372598</idno><idno type="pmid">15372598</idno><idno type="doi">10.1002/mds.20084</idno><idno type="wicri:Area/PubMed/Corpus">003353</idno><idno type="wicri:Area/PubMed/Curation">003353</idno><idno type="wicri:Area/PubMed/Checkpoint">003496</idno><idno type="wicri:Area/Ncbi/Merge">000F35</idno><idno type="wicri:Area/Ncbi/Curation">000F35</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of Parkinson's disease in patients with blepharospasm.</title><author><name sortKey="Micheli, Federico" sort="Micheli, Federico" uniqKey="Micheli F" first="Federico" last="Micheli">Federico Micheli</name><affiliation wicri:level="1"><nlm:affiliation>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina. fmicheli@fibertel.com.ar</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Scorticati, Maria Clara" sort="Scorticati, Maria Clara" uniqKey="Scorticati M" first="María Clara" last="Scorticati">María Clara Scorticati</name></author><author><name sortKey="Folgar, Silvia" sort="Folgar, Silvia" uniqKey="Folgar S" first="Silvia" last="Folgar">Silvia Folgar</name></author><author><name sortKey="Gatto, Emilia" sort="Gatto, Emilia" uniqKey="Gatto E" first="Emilia" last="Gatto">Emilia Gatto</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Botulinum Toxins, Type A (therapeutic use)</term><term>Brain (pathology)</term><term>Brain (physiopathology)</term><term>Brain (radiography)</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Meige Syndrome (diagnosis)</term><term>Meige Syndrome (drug therapy)</term><term>Meige Syndrome (epidemiology)</term><term>Neuromuscular Agents (therapeutic use)</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson Disease (physiopathology)</term><term>Severity of Illness Index</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term><term>Neuromuscular Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Meige Syndrome</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Meige Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Meige Syndrome</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="radiography" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Severity of Illness Index</term><term>Tomography, X-Ray Computed</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The liability to develop parkinsonian symptoms was evaluated in 105 outpatients with idiopathic blepharospasm (IBS; 54 cases) or IBS associated to oromandibular dystonia (Meige's syndrome; 51 cases) mean age 70.3 +/- 9.6 years, and compared with an age- and sex-matched population. Eleven patients developed Parkinson's disease in the blepharospasm group, whereas only 2 of 105 patients were affected in the control group. Our results suggest that patients with IBS either isolated or associated with oromandibular dystonia are more prone to develop parkinsonian symptoms.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000F35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:15372598
|texte= Development of Parkinson's disease in patients with blepharospasm.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:15372598" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |